SSY Group (HK:2005) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SSY Group Limited has entered a strategic framework agreement with HighTide Therapeutics, Inc., focusing on joint research and development in metabolic chronic diseases and anti-aging solutions. This partnership aims to leverage both companies’ strengths to create innovative products and promote them globally. The collaboration includes establishing a joint research center and building an industry ecosystem.
For further insights into HK:2005 stock, check out TipRanks’ Stock Analysis page.